# Pharmacokinetic Study of Single Doses of ORM-12741

> **NCT02319057** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ORM-12741 MR A
- **DRUG:** ORM-12741 IR
- **DRUG:** ORM-12741 MR B

## Key facts

- **NCT ID:** NCT02319057
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319057, "Pharmacokinetic Study of Single Doses of ORM-12741". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02319057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*